166 related articles for article (PubMed ID: 36559104)
1. Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells.
Unida V; Vindigni G; Raniolo S; Stolfi C; Desideri A; Biocca S
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559104
[TBL] [Abstract][Full Text] [Related]
2. Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells.
Unida V; Mangano E; Camboni T; Consolandi C; Desideri A; Severgnini M; Cifola I; Biocca S
Nanomedicine; 2023 Nov; 54():102710. PubMed ID: 37734452
[TBL] [Abstract][Full Text] [Related]
3. AS1411 Aptamer Linked to DNA Nanostructures Diverts Its Traffic Inside Cancer Cells and Improves Its Therapeutic Efficacy.
Vindigni G; Raniolo S; Iacovelli F; Unida V; Stolfi C; Desideri A; Biocca S
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683964
[TBL] [Abstract][Full Text] [Related]
4. Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures.
Raniolo S; Unida V; Vindigni G; Stolfi C; Iacovelli F; Desideri A; Biocca S
Cell Death Dis; 2021 Jan; 12(1):7. PubMed ID: 33414439
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages.
Raniolo S; Vindigni G; Ottaviani A; Unida V; Iacovelli F; Manetto A; Figini M; Stella L; Desideri A; Biocca S
Nanomedicine; 2018 Jun; 14(4):1181-1190. PubMed ID: 29458213
[TBL] [Abstract][Full Text] [Related]
6. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
7. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
[TBL] [Abstract][Full Text] [Related]
8. A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.
Yaghoobi E; Zavvar T; Ramezani M; Alibolandi M; Rahimzadeh Oskuei S; Zahiri M; Alinezhad Nameghi M; Abnous K; Taghdisi SM
J Drug Target; 2022 Dec; 30(10):1106-1112. PubMed ID: 35736221
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
[TBL] [Abstract][Full Text] [Related]
10. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
Liu X; Wu L; Wang L; Jiang W
Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer.
Wan Q; Zeng Z; Qi J; Chen Z; Liu X; Zu Y
Mol Ther; 2022 Jun; 30(6):2242-2256. PubMed ID: 35143958
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
Fang K; Wang L; Huang H; Dong S; Guo Y
Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
[TBL] [Abstract][Full Text] [Related]
13. Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells.
Taghavi S; Nia AH; Abnous K; Ramezani M
Int J Pharm; 2017 Jan; 516(1-2):301-312. PubMed ID: 27840158
[TBL] [Abstract][Full Text] [Related]
14. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
16. Folate-Functionalized DNA Origami for Targeted Delivery of Doxorubicin to Triple-Negative Breast Cancer.
Pal S; Rakshit T
Front Chem; 2021; 9():721105. PubMed ID: 34485245
[TBL] [Abstract][Full Text] [Related]
17. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
Lohlamoh W; Soontornworajit B; Rotkrua P
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
[TBL] [Abstract][Full Text] [Related]
18. Entry, fate and degradation of DNA nanocages in mammalian cells: a matter of receptors.
Raniolo S; Vindigni G; Unida V; Ottaviani A; Romano E; Desideri A; Biocca S
Nanoscale; 2018 Jul; 10(25):12078-12086. PubMed ID: 29911715
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer.
Wang N; Yu C; Xu T; Yao D; Zhu L; Shen Z; Huang X
J Nanobiotechnology; 2022 Nov; 20(1):486. PubMed ID: 36403038
[TBL] [Abstract][Full Text] [Related]
20. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
